204 related articles for article (PubMed ID: 2411399)
21. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
[TBL] [Abstract][Full Text] [Related]
22. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis.
Chen SF; Ruben RL; Dexter DL
Cancer Res; 1986 Oct; 46(10):5014-9. PubMed ID: 3019518
[TBL] [Abstract][Full Text] [Related]
24. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761
[TBL] [Abstract][Full Text] [Related]
25. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
Moran RG; Scanlon KL
Cancer Res; 1991 Sep; 51(17):4618-23. PubMed ID: 1831402
[TBL] [Abstract][Full Text] [Related]
26. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells.
Cory JG; Breland JC; Carter GL
Cancer Res; 1979 Dec; 39(12):4905-13. PubMed ID: 498116
[TBL] [Abstract][Full Text] [Related]
27. Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil.
Ghoshal K; Jacob ST
Cancer Res; 1994 Feb; 54(3):632-6. PubMed ID: 8306322
[TBL] [Abstract][Full Text] [Related]
28. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
[TBL] [Abstract][Full Text] [Related]
29. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
Diasio RB; Schuetz JD; Wallace HJ; Sommadossi JP
Cancer Res; 1985 Oct; 45(10):4900-3. PubMed ID: 3928143
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity.
Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR
Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145
[TBL] [Abstract][Full Text] [Related]
31. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
Klubes P; Cerna I
Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
[TBL] [Abstract][Full Text] [Related]
32. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
el Hag IA; Jakobsson B; Christensson PI; Erichsen C; Jönsson PE; Stenram U
In Vivo; 1987; 1(5):309-12. PubMed ID: 2485133
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment of colon carcinoma cells with Tomudex enhances 5-fluorouracil cytotoxicity.
Longo GS; Izzo J; Chang YM; Tong WP; Zielinski Z; Gorlick R; Chou TC; Bertino JR
Clin Cancer Res; 1998 Feb; 4(2):469-73. PubMed ID: 9516938
[TBL] [Abstract][Full Text] [Related]
34. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells.
Cadman E; Heimer R; Benz C
J Biol Chem; 1981 Feb; 256(4):1695-704. PubMed ID: 6161926
[TBL] [Abstract][Full Text] [Related]
35. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line.
Grem JL; Mulcahy RT; Miller EM; Allegra CJ; Fischer PH
Biochem Pharmacol; 1989 Jan; 38(1):51-9. PubMed ID: 2462882
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells.
Keniry M; Benz C; Shafer RH; James TL
Cancer Res; 1986 Apr; 46(4 Pt 1):1754-8. PubMed ID: 3456267
[TBL] [Abstract][Full Text] [Related]
37. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
Armstrong RD; Diasio RB
Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
[TBL] [Abstract][Full Text] [Related]
38. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
39. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
Takimoto CH; Cadman EC; Armstrong RD
Mol Pharmacol; 1986 Jun; 29(6):637-42. PubMed ID: 2940459
[TBL] [Abstract][Full Text] [Related]
40. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.
Cao D; Russell RL; Zhang D; Leffert JJ; Pizzorno G
Cancer Res; 2002 Apr; 62(8):2313-7. PubMed ID: 11956089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]